Haemonetics (HAE) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.85 -0.07%
Revenue Growth %: +5.5%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: +5.5%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $346 million versus the consensus estimate of $337.04 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Lowered to $92 at Mizuho
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
